2007 Midyear Clinical Meeting
ASHP Midyear 07 Session Detail
Gene Therapy: Science, History, and Implications for Pharmacy Practice
Track: Educational Session
Program Code: 280-L04
Date: Wednesday, December 5, 2007
Time: 8:00 a.m. - 9:30 a.m.
Location:
Bellini 2005/2006/2105/2106MEETING PLANNING ASSOCIATE:
Ms. Cynthia Reilly, RPh, Director, Clinical Standards and Quality, Practice Standards and Quality Division, American Society of Health-System Pharmacists
MODERATOR:
Ms. Cynthia Reilly, RPh, Director, Clinical Standards and Quality, Practice Standards and Quality Division, American Society of Health-System Pharmacists
PRESENTERS:
Ms. Cynthia Reilly, RPh, Director, Clinical Standards and Quality, Practice Standards and Quality Division, American Society of Health-System Pharmacists
Dr. Theresa Mays, PharmD, BCOP, Director, Investigational Drug Section, START
LEARNING OBJECTIVES
- Define the goals and principles of gene therapy.
- Explain the history of gene therapy clinical trials, diseases, and conditions that have been studied, and areas where future research is expected.
- Describe factors that pharmacy should address in policies and procedures related to gene therapy.